ArticleThe World Allergy Organization journal2025
Unequal contributions in global allergy research: A comparative study of high-, low-, and middle-income countries.
Article in The World Allergy Organization journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Global research trends in the epidemiology of allergic disorders: a bibliometric and evidence-mapping review.Frontiers in medicine · 2026Pooled it
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Global disparities in scientific research disproportionately favor high-income countries (HICs), limiting contributions from low- and middle-income countries (LMICs). In allergology, this inequity restricts diverse perspectives and constrains advancements in addressing allergic diseases, which disproportionately affects underserved populations. Methods: This study analyzed the contributions of 41 allergy journals listed in the 2024 Results: LMICs accounted for only 18.6% of the total publications, compared to a median of 85% from HICs, and only 1 journal included a low-income country among its top contributors. Journals received contributions from a median of 8 HICs versus 2 LMICs. APCs presented a median cost of 3090 USD, posing a significant financial barrier. Geographic alignment was observed between editorial boards and contributing countries, further limiting LMIC representation. Conclusion: Systemic barriers, including high APCs numbers and underrepresentation on editorial boards, limit the contribution in global allergology. Addressing these disparities requires reducing financial obstacles, expanding capacity-building initiatives, and ensuring equitable editorial representation. Creating inclusive research ecosystems can enhance global knowledge dissemination and improve outcomes for populations disproportionately affected by allergic diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.